Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Studying samples of blood and tumor tissue in the laboratory from patients with
cancer receiving chemotherapy may help doctors understand the effect of chemotherapy on
biomarkers. It may also help doctors predict how patients will respond to treatment.
PURPOSE: This phase IV trial is studying biomarkers in patients undergoing chemotherapy for
metastatic colorectal cancer.